When to stop treating lupoid hepatitis
Postgraduate Medicine 50(6): 180-181
1971
ISSN/ISBN: 0032-5481 PMID: 5128039 Document Number: 40712
Document emailed within 1 workday
Related Documents
Tareev, E.M.; Aprosina, Z.G.; Semendiaeva, M.E.; Traianova, T.G. 1975: Role of immunodepressants in the treatment of chronic active (lupoid) hepatitis Vestnik Akademii Meditsinskikh Nauk SSSR 6: 64-70Poulsen, L.O.; Thulstrup, A.M.; Mellemkjaer, L.; Vilstrup, H.; Sørensen, H.T. 2002: Mortality and causes of death in patients with "lupoid hepatitis." a long-term follow-up study in Denmark Danish Medical Bulletin 49(3): 263-265
Jabbour, E. 2014: Treating myelodysplastic syndrome when hypomethylating agents stop working Clinical Advances in Hematology and Oncology: H&o 12(4): 257-259
Jabbour, E. 2014: Treating myelodysplastic syndrome when hypomethylating agents stop working Clinical Advances in Hematology and Oncology: H&o 12(4): 257-259
Aungst, H. 2008: Patients say the darnedest things. you can't stop online ratings, but you can stop fretting about them Medical Economics 85(23): 27-29
Bobbio, M. 2000: To stop or not to stop a clinical trial: that is the problem Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 1(12): 821-823
Firkin, B.G.; Buchanan, R.R.; Pfueller, S.; Ryan, P. 1987: Lupoid thrombocytopenia Australian and New Zealand Journal of Medicine 17(3): 295-300
Kirby, J.; Munro, D.D. 1976: Lupoid sycosis British Journal of Dermatology 95 Suppl. 14: 59-60
Kaplan, P.E.; Betts, H.B. 1977: Lupoid sclerosis: evaluation and treatment Archives of Physical Medicine and Rehabilitation 58(1): 24-28
Perronne, C. 2005: Workshop report treating hepatitis C in HIV-infected patients: where are we now? Antiviral Therapy 10(5): 691-694
Lebenzon, S.S.; Maianskiĭ, D.N.; Gavrilova, N.I.; Kutina, S.N. 1988: Use of prodigiozan and zymosan in treating children with viral hepatitis a Pediatriia 6: 27-30
Triki, A.; Zouari, A.; Loukil, C.; Karray, A.; Rekik, A. 1983: Lupoid nephrotic syndrome. Apropos of 2 cases La Tunisie Medicale 61(6): 405-408
Benhamou, Y. 2006: Treating chronic lamivudine-resistant hepatitis B in HIV co-infected patients Gastroenterologie Clinique et Biologique 30(10 Part 2): 3s22-3s25
Yu, Y.; Si, C.; Zeng, Z.; Wang, Q.; Zhou, X.; Zhang, Q.; Huang, Z.; Zhang, L.; Qiao, G. 2001: A clinical trial of oxymatrine in treating chronic viral hepatitis type B Zhonghua Nei Ke Za Zhi 40(12): 843-846
Gatti, F.; Nasta, P.; Matti, A.; Manno, D.; Mendeni, M.; Puoti, M.; Carosi, G. 2007: Treating hepatitis C virus in HIV patients: are side effects a real obstacle? Aids Reviews 9(1): 16-24
Gabrilovich, D.I.; Musarov, A.L.; Zmyzgova, A.V.; Shalygina, N.B. 1990: The use of hyperbaric oxygenation in treating viral hepatitis B and the reaction of the blood leukocytes Terapevticheskii Arkhiv 62(1): 82-86
Bai, H.-l.; Luo, H.-t.; Ye, Y.-n.; Long, H.; Zhong, R.-x. 2010: Observation on effect of peg interferon lphaa-2a treating lamivudine resistant chronic hepatitis B Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 24(3): 230-231
Oleĭnik, A.N.; Skakun, N.P.; Bogachik, L.I.; Andreĭchin, M.A. 1976: Inductive action of phenobarbital in treating patients with the residual manifestations of past viral hepatitis Vrachebnoe Delo 1: 139-141
Gaĭdarski, R.; Dobrev, I.; Viiachki, I.; Khristov, I.; Tankov, I. 1982: Periarterial neurectomy of the common hepatic artery as a method of treating certain forms of acute and chronic hepatitis Khirurgiia 35(2): 145-151
Marfil Rivera, L.J.; Mares Ramírez, M.A.; Mora Brondo, P.; Rivera González, J.A.; Gómez Almaguer, D. 1986: Deep venous thrombosis in a patient with brucellosis and a probable lupoid inhibitor. Report of a case Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 38(3): 311-315